Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2013) 32 P396 | DOI: 10.1530/endoabs.32.P396

Armed Forces University Hospital, Lisbon, Portugal.


Introduction: Type 2 diabetes mellitus (T2DM) is a chronic disease, with prevalence increasing worldwide and its complications are major causes of early morbidity and mortality. Recent guidelines suggest the individualisation of glycaemic targets and glucose-lowering therapies.

The aim of this study was to determine the quality of care provided to type 2 diabetic patients in our institution, analysing metabolic control, cardiovascular risk factors and prevalence of diabetic complications.

Methods: Transversal study with 423 type 2 diabetic patients, followed at our diabetes clinic.

Results: A total of 423 patients were included in the study, with a mean age of 67±9.4 years. 61.7% were men. Approximately 90% of patients were overweight (41.9% obese). 65.3% had familiar history of T2DM. Mean duration of diabetes was 15±10.5 years and HbA1c levels averaged 7.0±1.2%. 60% had HbA1c ≤7% (40% HbA1c ≤6.5%). Concerning therapeutic regimens: 75% used oral hypoglycaemic agents (OAD) alone (73.4% of these were using two or more agents); 25% were treated with insulin (16% in combination with OAD). 82.3% of the patients had hypertension and 31.2% met the target blood pressure (BP) of 130/80 mmHg. 82.9% had dyslipidaemia and 62.6% met the goal LDL cholesterol level <100 mg/dl. 12% of patients met the combined ADA goal for BP, LDL, and HbA1c. 61.3% of the patients was anti-aggregated.Regarding diabetic complications: 16.7% had retinopathy, 26.4% nephropathy, 23% cardiovascular, and 8.7% cerebrovascular disease.

Conclusions: Metabolic control (HbA1c), BP, and LDL values were favourable in our patients, comparing to other studies. Although, it’s challenging to achieve all the goals proposed by international guidelines.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts